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gamma less than unity at the 3% / 3 mm level.  The dose at 
the treatment isocentre was also measured using a Farmer 
ionisation chamber and treatment times were recorded. 
Results:  A typical treatment plan is shown in Figure 1, 
together with the predicted portal image, the measured 
portal image and the gamma comparison.  Table 1 
summarises the results for all plans and patients.  Predicted 
images show particularly good agreement for conformal and 
limited-modulation VMAT plans due to the simplicity of the 
plans, but the agreement is also acceptable for the 
considerably more complex hybrid plans. 
 
 
 
Conclusions:  Portal dosimetry can be carried out accurately 
and effectively for hybrid IMRT and VMAT treatments.  The 
25% IMRT hybrid plan is of most interest practically as it 
offers improved dosimetry without taking a long time to 
deliver, and this plan shows acceptable accuracy of 
verification with portal dosimetry. 
 
Keywords: portal dosimetry, IMRT, VMAT 
 
References: 
[1] Matuszak MM, Steers JM, Long T, McShan DL, Fraass BA, 
Romeijn HE, Ten Haken RK.  FusionArc optimization: a hybrid 
volumetric modulated arc therapy (VMAT) and intensity 
modulated radiation therapy (IMRT) planning strategy.  Med 
Phys 2013;40:071713. 
[2] Robar JL, Thomas C.  HybridArc: A novel radiation 
therapy technique combining optimized dynamic arcs and 
intensity modulation.  Med Dosim 2012;37:358-68. 
[3] Bedford JL, Hanson IM, Hansen VN.  Portal dosimetry for 
VMAT using integrated images obtained during treatment.  
Med Phys 2014;41:021725. 
 
18 
Implementation of an analytical solution to lateral dose 
prediction in a proton therapy treatment planning 
system. 
E. V. Bellinzona1,2,3, G. Landry3, A. Fontana2, A. Embriaco1,2, 
A. Resch3,6, M. Ciocca4, A. Ferrari5, F. Kamp6,7, A. Mairani4,8, 
P. Sala9, T. Tessonnier8, J. Wilkens6, A. Rotondi1,2, K. 
Parodi3,8 
1 Dipartimento di Fisica, Università degli Studi di Pavia, 27100 
Pavia, Italy 
2 Istituto Nazionale di Fisica Nucleare (INFN), Sezione di 
Pavia, 27100 Pavia, Italy 
3 Department of Medical Physics, Ludwig Maximilians 
University, Munich, Germany  
4 Centro Nazionale di Adroterapia Oncologica (CNAO), 27100 
Pavia, Italy 
5 European Organization for Nuclear Research CERN, CH-
1211, Geneva 23, Switzerland 
6 Department of Radiation Oncology, Technische Universität 
München, Klinikum rechts der Isar, Munich D81675, Germany 
7 Department of Radiation Oncology, Ludwig-Maximilians-
University, Marchioninistr. 15, 81377 München, Germany 
8 Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, 
Germany 
9 Istituto Nazionale di Fisica Nucleare (INFN), Sezione di 
Milano, 20133 Milano, Italy 
 
Purpose: This work aims to present a flexible 
computational model for the calculation of the lateral 
deflection of a pencil proton beam, and the 
preliminary results of its implementation in a 
Treatment Planning System (TPS) instead of the 
currently used Double Gaussian approximation (DGA) in 
water. 
First evidences show that the model has better accuracy 
with fast computation time in water; it is reliable for any 
depth and for every kind of media and mixture, since 
energy loss effects by the primary process are fully taken 
into account. 
Methods: Challenging issues in TPS for hadrontherapy 
are the accurate calculation of dose distribution, the 
reduction in memory space required to store the dose 
kernel of individual pencil beams and the shortening of 
computation time for dose optimization and calculation. 
In this framework, prediction of lateral dose 
distributions is a topic of great interest because, 
currently, a DGA [1], [2] is typically used as 
approximation; although other parameterizations are also 
available [3], [4], [5]. The best accuracy in this kind of 
calculations can be obtained by Monte Carlo (MC) 
methods [6], but at the expense of a too long computing 
time. 
As alternative, we propose a flexible model based on the 
full Molière theory for Coulomb multiple scattering [7]. 
The use of the original equations of the theory allows to 
remove any free parameter for the electromagnetic 
interaction with the advantage of full accuracy with a 
reasonable increase in the computing time. The 
contribution of the nuclear interactions are also fully 
taken into account with a two-parameters fit, on FLUKA 
simulation [8],[9]; this part is added to the 
electromagnetic core with a proper weight [10]. 
Model is currently under testing in a particle therapy 
extension of CERR - A Computational Environment for 
Radiotherapy Research [11], [12] TPS, in order to compare 
the results with the actual dose prediction in water. 
Results and Conclusions: The model has been first 
compared to MC predictions for protons in water, for 
different depths and therapeutic energies, and also 
with some experimental data from Heidelberg Ion-Beam 
Therapy Center (HIT), generally showing very good 
agreement. 
The comparison of the CERR dose distribution 
calculated using DGA with the one predicted by the 
computational model is shown in Figure 1 together with 
FLUKA MC prediction. 
The DGA has a lateral cutoff distance from the central ray 
that is used to determine the points that do not require 
dose calculation that has been set at maximum possible 
value 4 (in multiples of the gaussian lateral extend at the 
end of the decay area). 
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Fig.1 Comparison between Fluka MC simulation (red line), 
dose distribution evaluated with CERR using Double 
Gaussian model (green line) and dose predicted by 
standalone computational model (blue line) for a proton 
initial beam energy of 60MeV, initial σ  of 0.4cm, at a 
normalized depth 0.9 (assuming Bragg peak position at 1) 
 
The preliminary results show that the model is able to 
predict dose with better accuracy than DGA. 
So, this model could be a step forward in lateral dose 
prediction for current TPS and as a future application, a 
useful tool for online dose-evaluation and adaptive 
planning; next step will be the implementation of different 
media and geometries. 
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Purpose: To define the clinical protocol for Head and Neck 
(H&N) patients treated with Proton Pencil Beam Scanning 
(PBS) at Paul Scherrer Institute (PSI, Villigen CH) with 
Simultaneous Integrated Boost (SIB). The focus was mainly to 
define the optimization parameters and the normalization 
procedure to obtain a steep gradient between the elective 
and the boost volume, in order to reduce over-dosage in the 
fall off area of the boost.  
Material and Methods: 7 patients, treated at PSI for different 
H&N carcinomas, were selected for this study. They were all 
originally treated with two sequential series at 2GyRBE;  the 
1st one up to 54GyRBE to the elective Planning Target Volume 
(PTV1), followed by a second series up to 72GyRBE for the 
boost target volume (PTV2). In this study, all have been re-
planned using a SIB regimen of 1.8GyRBE (up to 54GyRBE) to 
PTV1 and 2.36GyRBE (up to 70.8GyRBE) to PTV2 for a total of 
30 fractions. Dose constraints to the OARs were kept as for 
the sequential approach [1]. All plans were designed on the 
PSIPlan Treatment Planning System using Intensity Modulated 
Proton Therapy (IMPT) with non-coplanar fields. The 
prescription dose of 100% corresponded to the average dose 
to PTV1, while the dose to PTV2 was optimized prescribing a 
boosting factor based on the ratio of the two different 
prescribed dose levels (i.e. 54GyRBE and 70.8 GyRBE). 
Depending on the ratio of the PTV1 and PTV2 volumes the 
boosting factor was prescribed to PTV2 or to a smaller 
structure (GTV or PTV2-3mm). To guarantee dose 
homogeneity in the dose gradient region between PTV1 and 
PTV2, the optimized SIB plans were normalized such that 
54GyRBE corresponded to the average dose to [PTV1-(Boost 
volume+3mm)]. This avoided over-dosages close to PTV2 
being compensated by under-dosages at the PTV1 margin.  
Results:  The choice of the boosted volume, the boosting 
factor, the quality and conformity of the SIB plans were 
observed to be dependent on the volume ratio PTV2/PTV1. 
For the analyzed patients, this ranged from 28.8% to 61.7%. 
For differences in the PTV1 to PTV2 volume larger than 40%, 
either a PTV2-3mm or the GTV itself were selected for the 
boosting. Else no gradient could be observed. When 
compared to the nominal sequential plan, the SIB approach 
resulted in both a lower mean dose to the ring area (average 
value for SIB: 55.2+1.0 GyRBE; average value for sequential: 
64.1+3.6 GyRBE), and 0.6+0.4% as average ring volume 
receiving the 95% of the dose prescribed to the boost (the 
same dose parameter was >10% for all the original plans). A 
similar sparing of OARs was obtained with both treatment 
schedules. 
Conclusion:  Planning H&N patients with SIB optimization 
resulted in dose distributions which guaranteed the PTV2 and 
PTV1 coverage and conformity whilst keeping dose to OARs 
within tolerance. Therefore this approach can be transferred 
to the clinical operation and has already been applied to a 
first patient.  
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Gamma locator is a handheld lightweight and compact 
gamma probe based on a scintillation crystal LaBr3:Ce and 
silicone photomultiplier to be used for detection of gamma-
radiation emitted by radionuclides such as 99mTc, 125I, 111In, 18F 
[1]. 
There are two main applications of gamma locator: 
intraoperative detection of sentinel lymph nodes and non-
invasive scanning the surface of the body. In the first case, a 
radiotracer is injected into the patient preoperatively and 
